EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Mitochondrial Dysfunction in Alzheimer’s Disease Neurons: Lithium Boosts Oxidative Phosphorylation

Benedict C Albensi, Aida Adlimoghaddam

Cells · 2026

DOI: 10.3390/cells15100896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Benedict C Albensi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Barry & Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Oxidative Phosphorylation, Mitochondria, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Association, Alzheimer’s Association, Research Manitoba award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is characterized by the accumulation of amyloid beta (Aβ) and neurofibrillary tangles in brain tissue; however, AD is multifactorial, and different etiopathogenic mechanisms involve factors that can affect mitochondrial function, which are associated with AD. While high-dose lithium is a well-established mood stabilizer, accumulating evidence suggests that low-dose lithium provides significant neuroprotection by reversing AD pathology, cognitive impairment, and inflammation. Despite these findings, there is limited information on how lithium affects brain energy metabolism. In the current study, we investigated the effect of lithium (0, 0.1, 1, and 10 mM) on mitochondrial function in AD neurons. Neuronal cells were isolated from the hippocampi of embryonic day 14–17 (E15–E17) control (C57BL/6) mice and 3xTg-AD mice. Mitochondrial oxygen consumption rate (OCR), mitochondrial Cytochrome C Oxidase (COX) activity, total ATP activity, and the expression of mitochondrial complex protein involved in oxidative phosphorylation (OXPHOS) were measured in control vs. 3xTg-AD in the presence and absence of lithium treatment. In the present study, lithium treatment significantly increased (p < 0.05) mitochondrial OCR, COX, total ATP, and levels of mitochondrial complex protein subunits (Complex I–V) in 3xTg-AD neurons. However, lithium had no effect on energy metabolism in control neurons. Together, these data indicate that lithium improves mitochondrial function under pathological states. Overall, these results have important implications for the treatment of disorders in which brain energy regulation is compromised, including AD. Particularly, our results highlight a role for lithium in regulating bioenergetics in early-stage AD and suggest that neuronal cells may be a crucial therapeutic target for preventing AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseOxidative PhosphorylationMitochondriaNeuronsLithiumAnimalsMiceMice, Inbred C57BLElectron Transport Complex IVMice, TransgenicEnergy MetabolismOxygen ConsumptionHippocampus

Stichwörter der Autor:innen

Alzheimer’s diseasebioenergeticslithiummitochondrial functionneuronsoxidative phosphorylation

Substanzen

LithiumElectron Transport Complex IV

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Barry & Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.
  • Division of Neurodegenerative Disorders, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.
  • Department of Pharmacology & Therapeutics, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0T6, Canada.
  • Department of Neurology, Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Neuroscience Institute, Southern Illinois University School of Medicine, Springfield, IL 62702, USA.
  • Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL 62702, USA.
  • Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL 62702, USA.

Förderung

  • Alzheimer's Association
  • Alzheimer’s Association
  • Research Manitoba award
  • St. Boniface Hospital Research Foundation
  • CIHR
  • NIH R16
  • Alzheimer’s Society of Manitoba

Zitieren

APA

Albensi, B. C., & Adlimoghaddam, A. (2026). Targeting Mitochondrial Dysfunction in Alzheimer’s Disease Neurons: Lithium Boosts Oxidative Phosphorylation. Cells. https://doi.org/10.3390/cells15100896

Vancouver

Albensi BC, Adlimoghaddam A. Targeting Mitochondrial Dysfunction in Alzheimer’s Disease Neurons: Lithium Boosts Oxidative Phosphorylation. Cells. 2026. doi:10.3390/cells15100896

BibTeX
@article{Albensi2026,
  author = {Albensi, Benedict C and Adlimoghaddam, Aida},
  title = {Targeting Mitochondrial Dysfunction in Alzheimer’s Disease Neurons: Lithium Boosts Oxidative Phosphorylation},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15100896}
}
Kostenlos starten →